pulmonari
complic
especi
acut
respiratori
failur
arf
contribut
morbid
mortal
immunocompromis
patient
etiolog
pathophysiolog
revers
lung
injuri
sever
arf
key
therapeut
respons
prognosi
patient
essenti
notion
evolut
arf
depend
causal
diseas
noninvas
ventil
niv
correct
primari
process
consid
measur
allow
us
gain
time
need
revers
primari
process
longer
niv
need
less
chanc
success
suggest
perhap
patient
appropri
one
subject
niv
advis
identifi
variou
scenario
immunosuppress
may
associ
arfpati
malign
inflammatori
diseas
among
identifi
two
group
immunosuppress
therapi
arf
mainli
associ
infect
recurr
underli
diseas
drug
toxic
noninfecti
diseas
without
immunosuppress
therapi
among
arf
predominantli
relat
progress
underli
diseas
noninfecti
diseasetranspl
patient
predominantli
infecti
pulmonari
complic
relat
drug
immunosuppress
drug
toxic
noninfecti
diseaseshuman
immunodefici
virusacquir
immunodefici
syndrom
hivaid
patient
among
arf
relat
predominantli
lung
infect
bacteri
pneumonia
pneumocysti
jirovecii
pneumonia
lung
infect
caus
opportunist
agent
p
jirovecii
noninfecti
diseas
hivaid
patient
arf
lead
caus
hospit
intens
care
unit
icu
bacteri
pneumonia
p
jirovecii
pneumonia
frequent
associ
entiti
surviv
situat
depend
mean
diagnos
manag
arf
causal
diseas
method
support
vital
function
includ
respiratori
function
caus
diseas
revers
support
respiratori
function
might
includ
use
oxygen
therapi
noninvas
positivepressur
ventil
niv
intub
mechan
ventil
mv
andor
extracorpor
oxygen
devic
although
mv
effect
reliabl
method
associ
increas
short
medium
longterm
morbid
mortal
relat
ventilationassoci
pneumonia
upper
airway
injuri
reduc
incid
complic
associ
effect
least
equival
mv
ration
foundat
develop
implement
niv
patient
throughout
text
niv
refer
positivepressur
mechan
ventil
without
airway
invas
niv
basic
includ
pressur
support
ventil
psv
posit
endexpiratori
pressur
peep
also
refer
bilevel
pressur
ventil
continu
posit
airway
pressur
cpap
retrospect
analysi
autopsi
patient
die
arf
constitut
autopsi
show
follow
patient
averag
age
year
male
overal
deceas
patient
singl
associ
diseas
two
three
three
patient
two
associ
diseas
histopatholog
reveal
lung
injuri
compat
acut
respiratori
distress
syndrom
ard
case
diffus
alveolar
damag
pulmonari
edema
alveolar
hemorrhag
inflammatori
involv
describ
interstiti
pneumonia
edema
alveolar
septa
infiltr
mononuclear
cell
histiocyt
plasma
cell
polymorphonuclear
neutrophil
evid
case
frequent
associ
diseas
bacteri
pneumonia
case
malign
sepsi
andor
septic
shock
hivaid
pattern
describ
interstiti
pneumonia
seen
predominantli
patient
hivaid
retrospect
analysi
autopsi
hivaid
patient
die
arf
show
follow
histopatholog
show
acut
interstici
pneumonia
edema
alveolar
septa
infiltr
mononuclear
cell
histiocyt
plasma
cell
polymorphonuclear
neutrophil
case
also
reveal
injuri
consist
ard
diffus
alveolar
damag
pulmonari
edema
alveolar
hemorrhag
deceas
patient
addit
hivaid
singl
diseas
associ
arf
identifi
patient
two
diseas
none
bacteri
pneumonia
frequent
associ
diseas
patient
p
jirovecii
pneumonia
second
frequent
seen
pulmonari
dissemin
tuberculosi
tb
found
sepsi
andor
septic
shock
cytomegaloviru
cmv
pneumonia
frequent
malign
diseas
kaposi
sarcoma
seen
case
p
jirovecii
pneumonia
associ
primarili
injuri
describ
acut
interstiti
pneumonia
sepsi
andor
septic
shock
diffus
alveolar
damag
lung
infect
signific
impact
among
caus
arf
hivaid
patient
risk
develop
infect
relat
sever
immunosuppress
region
epidemiolog
prophylaxi
frequent
isol
agent
clear
exampl
relat
region
epidemiolog
comparison
preval
pulmonari
tb
among
differ
popul
epidemiolog
lung
infect
chang
recent
decad
prophylaxi
p
jirovecii
sinc
avail
highli
activ
antiretrovir
therapi
haart
sinc
obviou
reason
although
p
jirovecii
pneumonia
replac
bacteri
pneumonia
common
lung
infect
continu
leader
among
caus
arf
infect
hiv
increas
incid
bacteri
pneumonia
tenfold
recurr
bacteri
pneumonia
includ
indic
diseas
aid
sinc
bacteri
pneumonia
especi
caus
streptococcu
pneumonia
pulmonari
tb
develop
number
tcell
still
accept
eg
cell
although
incid
increas
immun
function
declin
reason
initi
stage
diseas
bacteri
pneumonia
tb
clearli
predomin
gener
popul
pneumonia
frequent
isol
agent
hivaid
patient
communityacquir
pneumonia
bacteri
pneumonia
isol
known
agent
infect
opportunist
agent
develop
tlymphocyt
number
cell
haemophilu
influenza
isol
bacteri
pneumonia
especi
patient
significantli
lower
immun
function
evolut
subacut
half
patient
bilater
radiolog
identifi
lung
lesion
staphylococu
aureu
third
singl
agent
caus
bacteri
pneumonia
advis
rememb
intraven
drug
user
may
develop
endocard
tricuspid
valv
due
aureu
pulmonari
seed
manifest
multipl
cavitari
nodul
pseudomona
aeruginosa
infect
significantli
reduc
acquisit
agent
mostli
nosocomi
patient
today
less
frequent
shorter
hospit
pneumonia
due
mycoplasma
pneumonia
chlamydophila
pneumonia
appear
rel
uncommon
popul
systemat
studi
importantli
still
signific
popul
patient
undiagnos
hiv
yet
anoth
group
diagnosi
hiv
take
haart
type
prophylaxi
incid
infect
relat
agent
continu
describ
effect
treatment
came
avail
prospect
assess
hivposit
patient
hospit
lung
injuri
arf
show
follow
result
among
patient
diagnosi
bacteri
pneumonia
p
jirovecii
pneumonia
bacteri
pneumonia
cap
frequent
isol
agent
pneumonia
mycobacterium
tuberculosi
isol
four
patient
patient
p
jirovecii
pneumonia
diagnosi
hiv
receiv
specif
prophylaxi
haart
patient
haart
compar
monitor
regularli
hospit
pulmonari
lesion
seen
chest
radiographi
bilater
interstiti
involv
patient
bilater
consolid
unilater
consolid
radiolog
lesion
bilater
p
jirovecii
pneumonia
bacteri
pneumonia
cell
count
patient
p
jirovecii
pneumonia
compar
bacteri
pneumonia
respect
mortal
sampl
higher
patient
p
jirovecii
pneumonia
data
associ
increas
mortal
low
admiss
compar
result
previou
studi
show
patient
p
jirovecii
pneumonia
studi
develop
arf
versu
earlier
studi
episod
requir
intens
care
studi
compar
earlier
studi
number
sever
bacteri
pneumonia
also
reduc
introduct
haart
retrospect
evalu
hospit
patient
hivaid
arf
conduct
presenc
arf
reveal
diagnosi
hiv
patient
caus
arf
bacteri
pneumonia
patient
frequent
isol
agent
pneumonia
patient
develop
septic
shock
p
jirovecii
caus
pneumonia
patient
patient
previou
diagnosi
hiv
opportunist
infect
seen
patient
often
tb
noninfecti
diseas
heart
failur
chronic
obstruct
pulmonari
diseas
copd
perhap
relat
improv
surviv
patient
today
relat
diseas
chang
throughout
studi
period
two
caus
identifi
patient
associ
bacteri
pneumonia
p
jirovecii
opportunist
noninfecti
diseas
p
jirovecii
cmv
patient
haart
frequent
bacteri
pneumonia
noninfecti
diseas
opportunist
infect
patient
underw
niv
requir
mv
total
patient
requir
mv
vasopressor
inhospit
mortal
rate
around
chang
studi
period
differ
four
diagnost
categori
mortal
relat
need
mv
vasopressor
greater
interv
hospit
admiss
transfer
icu
number
caus
arf
identifi
associ
cell
count
viral
load
mortal
patient
hivaid
develop
arf
relat
multipl
etiolog
lung
injuri
howev
limit
pattern
must
forget
arf
treatment
mv
alveolar
overdistens
cyclic
open
close
airspac
gener
similar
lung
lesion
result
process
hypoxemia
without
hypercapnia
multipl
organ
failur
case
among
describ
mechan
hypoxemia
ventilationperfus
imbal
intrapulmonari
shunt
ie
perfus
alveolar
unit
littl
ventil
typic
relat
ard
evolut
ard
describ
three
stage
exud
stage
character
alter
alveolarcapillari
membran
permeabl
passag
fluid
rich
protein
cytokin
eg
interleukin
tumor
necrosi
factor
lipid
mediat
eg
leukotrien
cell
especi
activ
neutrophil
alveolar
space
involv
initi
mainten
progress
uncontrol
alveolar
interstiti
inflammatori
process
increas
permeabl
alveolarcapillari
membran
seem
consequ
alter
homophil
union
vecadherin
molecul
critic
protein
maintain
endotheli
cell
union
antivecadherin
antibodi
inflammatori
mediat
thrombin
vascular
endotheli
growth
factor
vegf
interrupt
union
allow
pulmonari
edema
moreov
aggreg
plasma
protein
remnant
necrot
cell
alter
surfact
accumul
form
intraalveolar
hyalin
membran
contribut
reduc
lung
complianc
gener
area
atelectasi
impair
ga
exchang
result
caus
increas
work
breath
dyspnea
pathophysiolog
phenomena
pulmonari
vasculatur
lead
pulmonari
arteri
hypertens
phenomena
includ
follow
endotheli
dysfunct
involv
imbal
vasodil
vasoconstrictor
mediatorspulmonari
vascular
occlus
intravascular
neutrophil
kidnap
propens
intravascular
coagulationincreas
vascular
tone
relat
alter
control
hypox
vasoconstrict
gener
irregular
area
vasoconstrict
increas
pulmonari
vascular
resist
togeth
vasodil
exagger
ventilationperfus
imbal
intrapulmonari
shunt
dysfunct
hypox
vasoconstrict
may
correl
specif
factor
patholog
process
eg
endotoxin
hypothermia
alkalosi
elev
left
atrial
pressur
treatment
institut
eg
agonist
agent
calcium
channel
blocker
nitroprussid
peep
extrins
vascular
occlus
relat
increas
alveolar
volum
peep
area
atelectasi
alveolar
edemavascular
remodel
later
stage
exud
stage
lung
inflamm
seem
driven
mainli
activ
innat
immun
respons
union
microbi
product
endogen
molecul
associ
cell
molecular
pattern
damp
recognit
receptor
pattern
eg
tolllik
receptor
pulmonari
epithelium
macrophag
pathway
may
also
particip
affect
inflammatori
process
intens
enzym
convert
angiotensin
balanc
cours
viral
infect
sepsi
alveolar
surfact
abnorm
includ
reduc
product
chang
phospholipid
composit
inhibit
alveolar
plasma
protein
promot
atelectasi
prolif
stage
begin
day
last
week
phase
evolut
surviv
patient
wean
mechan
ventil
lung
repair
begin
howev
case
progress
lung
damag
earli
chang
pulmonari
fibrosi
histolog
phase
character
organ
alveolar
exud
progress
replac
neutrophil
lymphocyt
prolifer
type
ii
pneumocyt
basal
membran
resolut
inflamm
requir
clearanc
neutrophil
alveoli
process
led
alveolar
macrophag
known
eferocitosi
emerg
alveolar
type
iii
procollagen
stage
marker
pulmonari
fibrosi
associ
prolong
clinic
pictur
increas
mortal
fibrot
stage
alveolar
architectur
profoundli
alter
acinar
ductal
fibrosi
appar
impair
lung
complianc
increas
alveolar
dead
space
fibrot
prolifer
intima
contribut
vascular
occlus
pulmonari
hypertens
potenti
impact
right
ventricular
function
basic
object
niv
implement
patient
correct
pulmonari
ga
exchang
reduc
work
breath
physiolog
effect
niv
implement
evalu
ten
patient
bilater
pulmonari
infiltr
associ
lung
infect
averag
cpap
peep
least
significantli
increas
result
suggest
implement
peep
cpap
favor
effect
oxygen
certain
level
also
would
relat
increas
function
residu
capac
depend
alveolar
recruit
stabil
appli
psv
significantli
reduc
allevi
dyspnea
reduc
burden
respiratori
muscl
work
breath
respiratori
drive
proport
psv
level
appli
increas
tidal
volum
vt
niv
particularli
cpap
peep
improv
respiratori
system
complianc
recruit
stabil
partial
total
collaps
alveoli
vt
increas
associ
intens
durat
reduct
respiratori
muscl
contract
reduc
work
breath
niv
reduc
inspiratori
effort
mean
esophag
pressur
pe
reduc
averag
transdiaphragmat
pressur
pdi
electromyograph
activ
diaphragm
rang
diaphragmat
time
pressur
product
ptpdi
reduc
averag
work
breath
result
explain
reduct
spontan
transpulmonari
pressur
inspir
psv
threshold
load
inspir
achiev
balanc
intrins
peep
elast
load
inspir
increas
respiratori
complianc
cpap
peep
ptpdi
work
breath
improv
effect
combin
psv
cpap
peep
rather
use
either
alon
patient
arf
ard
cpap
reduc
ptpdi
wherea
combin
psv
peep
reduc
fig
seem
differ
reduct
work
breath
psv
proport
assist
ventil
appli
furthermor
effect
psv
set
work
breath
reduct
eg
pressur
rate
rise
time
alway
comfort
patient
implement
psv
valu
enabl
progress
improv
indic
work
breath
reduct
relat
ushap
toler
curv
lowest
highest
valu
worst
toler
best
result
obtain
peep
valu
psv
hemodynam
impact
posit
pressur
seem
relat
peep
cpap
least
interfac
allow
leakag
oper
mechan
depend
balanc
reduct
venou
return
afterload
left
ventricl
result
suggest
oper
seek
best
combin
level
peep
cpap
psv
offer
improv
oxygen
reliev
stress
respiratori
muscl
limit
peak
pressur
thu
reduc
leak
facilit
patient
adapt
method
howev
pulmonari
complianc
reduc
ard
less
chanc
success
implement
niv
patient
select
must
includ
consider
indic
contraind
use
niv
absolut
rel
advis
oper
understand
benefit
method
make
decis
regard
indic
start
itind
nivmoder
sever
dyspnearespiratori
rate
accessori
muscl
paradox
patient
riskunderli
diseas
revers
short
termaccept
consciousnesshemodynam
stabilityno
major
organ
dysfunct
lungsdiseas
categori
global
high
simplifi
acut
physiolog
score
ii
sap
ii
precautionsard
pneumoniaarrhythmia
cardiac
ischemiadifficulti
manag
bronchorrhea
exclusionsrespiratori
cardiac
arrestlack
patient
cooperationuncontrol
vomit
activ
gastrointestin
bleedingmask
method
intolerancefaci
deform
injuri
prevent
appli
maskimmedi
orofaci
esophag
gastric
surgeri
initi
niv
patient
arf
recommend
use
equip
provid
precis
stabl
offer
possibl
monitor
effect
ventil
graph
measur
also
alarm
program
leakag
compens
variou
ventil
mode
best
interfac
total
face
mask
oronas
mask
helmet
recommend
start
mode
psv
peep
recommend
implement
psv
peep
suggest
interfac
secur
level
psv
progress
increas
expir
tidal
volum
mlkg
respiratori
rate
cycl
per
minut
peep
progress
increas
increment
reach
maintain
peak
pressur
kept
ideal
patient
monitor
continu
first
h
strict
monitor
patient
evolut
need
unit
niv
appli
note
base
patient
evolut
toler
period
spontan
breath
initi
special
care
avoid
rapid
progress
usual
harm
sever
factor
predict
niv
failur
age
yearsard
nacsap
ii
apach
ii
rate
h
niv
initiatedshocksever
hypoxemia
h
start
niv
sever
indic
switch
niv
mv
failur
maintain
mmhg
requir
high
pressur
peakslack
improv
trend
regard
dyspnea
andor
ga
exchangemask
method
intolerancedifficulti
manag
respiratori
secretionshemodynam
deteriorationneurolog
impair
even
niv
seem
simpl
method
encourag
result
low
risk
import
note
featur
depend
techniqu
employ
optim
train
updat
team
success
also
depend
properli
select
patient
method
suitabl
appli
especi
failur
quickli
acknowledgednot
recogn
failur
method
obtain
desir
result
delay
appli
mv
time
fashion
main
sourc
seriou
complic
relat
niv
